Form 4 Filing for Century Therapeutics, Inc. - Officer Stock Transaction

This filing details a transaction by Chad Cowan, Chief Scientific Officer of Century Therapeutics, Inc. On April 1, 2026, Mr. Cowan disposed of 1,365 shares of Common Stock at a price of $2.19 per share, resulting in a post-transaction share count of 1,175,680. The shares were withheld by the Issuer to cover tax obligations related to restricted stock units. Additionally, Mr. Cowan holds 10,697 shares indirectly through the Cowan Investment Nominee Trust, for which he disclaims beneficial ownership beyond his pecuniary interest.